Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concern

Blocking the interaction of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with its angiotensin-converting enzyme 2 (ACE2) receptor was proved to be an effective therapeutic option. Various protein binders as well as monoclonal antibodies that effectively target the receptor-binding do...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen-Dvashi, Hadas, Weinstein, Jonathan, Katz, Michael, Eilon-Ashkenazy, Maayan, Mor, Yuval, Shimon, Amir, Achdout, Hagit, Tamir, Hadas, Israely, Tomer, Strobelt, Romano, Shemesh, Maya, Stoler-Barak, Liat, Shulman, Ziv, Paran, Nir, Fleishman, Sarel Jacob, Diskin, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514956/
https://www.ncbi.nlm.nih.gov/pubmed/36188189
http://dx.doi.org/10.1016/j.isci.2022.105193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514956/
https://www.ncbi.nlm.nih.gov/pubmed/36188189
http://dx.doi.org/10.1016/j.isci.2022.105193

Ejemplares similares